AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14651538 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen lysine 10 mg/kg, followed by 5 mg/kg after 24 and 48 h (n = 32)
Number of subjects: 63
Study 14651538 — intervention group
Group type: COMPARATOR
Intervention: Intravenous indomethacin 0.2 mg/kg every 12 h for three doses (n = 31)
Number of subjects: 63
Study 10768530 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-time splint wear instructions
Number of subjects: 21
Study 10768530 — intervention group
Group type: COMPARATOR
Intervention: Night-only splint wear instructions
Number of subjects: 21
Study 10768530 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sample
Number of subjects: 21
Study 8678624 — intervention group
Group type: EXPERIMENTAL
Intervention: CD14 expression in monocytes
Number of subjects: 213
Study 8678624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean fluorescence intensity (MC CD14)
Number of subjects: 213
Study 1873206 — intervention group
Group type: EXPERIMENTAL
Intervention: MC903 (vitamin D3 analogue)
Number of subjects: 15
Study 1873206 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 15
Study 6356902 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (100 mg twice a day)
Number of subjects: 57
Study 6356902 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol (400 mg twice a day, maximum dose)
Number of subjects: 57
Study 6356902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 30362147 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide sodium
Number of subjects: 0
Study 30362147 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 0
Study 29019319 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 2125
Study 29019319 — intervention group
Group type: COMPARATOR
Intervention: Carotid Artery Stenting (CAS)
Number of subjects: 2125
Study 27552322 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatekeeper training for nursing home staff
Number of subjects: 24
Study 27552322 — intervention group
Group type: COMPARATOR
Intervention: No gatekeeper training for nursing home staff
Number of subjects: 24
Study 25101576 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable stent implantation (BASI)
Number of subjects: 80
Study 25101576 — intervention group
Group type: COMPARATOR
Intervention: Common femoral artery endarterectomy (CFE)
Number of subjects: 80
Study 23234082 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Reconstruction group
Number of subjects: 58
Study 23234082 — intervention group
Group type: EXPERIMENTAL
Intervention: Transactional Analysis group
Number of subjects: 58
Study 23234082 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth group
Number of subjects: 58
Study 23234082 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling groups
Number of subjects: 58
Study 23234082 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 58
Study 23234082 — intervention group
Group type: COMPARATOR
Intervention: Leaders and members
Number of subjects: 58
Study 19936896 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0
Study 19936896 — intervention group
Group type: EXPERIMENTAL
Intervention: PBPK model predictions
Number of subjects: 0
Study 19936896 — intervention group
Group type: EXPERIMENTAL
Intervention: PBPK model with empirical scaling factor
Number of subjects: 0
Study 19936896 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspecies difference in elimination rate
Number of subjects: 0
Study 17228348 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counselling on diet and leisure time physical activity (LTPA) during five routine visits to a public health nurse until 37 weeks' gestation.
Number of subjects: 105
Study 17228348 — intervention group
Group type: COMPARATOR
Intervention: Standard maternity care (control group).
Number of subjects: 105
Study 15387489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent antegrade warm blood hyperkalemic cardioplegia with magnesium
Number of subjects: 20
Study 15387489 — intervention group
Group type: COMPARATOR
Intervention: Intermittent antegrade warm blood hyperkalemic cardioplegia without magnesium
Number of subjects: 20
Study 11457629 — intervention group
Group type: EXPERIMENTAL
Intervention: CATCH physical education intervention
Number of subjects: 96
Study 11457629 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom teachers
Number of subjects: 96
Study 11457629 — intervention group
Group type: EXPERIMENTAL
Intervention: PE specialists
Number of subjects: 96
Study 11457629 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 9728822 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention
Number of subjects: 127
Study 9728822 — intervention group
Group type: COMPARATOR
Intervention: Nonvideo control
Number of subjects: 127
Study 9728822 — intervention group
Group type: EXPERIMENTAL
Intervention: Low trait anxiety scores
Number of subjects: 127
Study 8680787 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of recombinant tissue plasminogen activator (tPA) compounded in 1% hyaluronate acid (HA) at doses of 0.25, 0.5, and 1.0 mg/ml for 4 weeks
Number of subjects: 12
Study 8680787 — intervention group
Group type: COMPARATOR
Intervention: Placebo (HA alone)
Number of subjects: 12
Study 2805375 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 100
Study 2805375 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 100
Study 1220835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytopipette (postal 'do-it-yourself' method)
Number of subjects: 0
Study 1220835 — intervention group
Group type: COMPARATOR
Intervention: Conventional cervical scrape examination (invitation to attend a clinic or see a general practitioner)
Number of subjects: 0
Study 29617755 — intervention group
Group type: EXPERIMENTAL
Intervention: Activator
Number of subjects: 60
Study 28721886 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (twice-weekly classes during RT)
Number of subjects: 68
Study 28721886 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 68
Study 28721886 — intervention group
Group type: COMPARATOR
Intervention: No-yoga control group
Number of subjects: 68
Study 25980426 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 alone
Number of subjects: 224
Study 25980426 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 + PPSV23 in contralateral arms
Number of subjects: 224
Study 25980426 — intervention group
Group type: EXPERIMENTAL
Intervention: MF59-aIIV3 + PPSV23 in the same arm
Number of subjects: 224
Study 25980426 — intervention group
Group type: COMPARATOR
Intervention: PPSV23 alone
Number of subjects: 224
Study 25980426 — intervention group
Group type: EXPERIMENTAL
Intervention: PPSV23
Number of subjects: 224
Study 23438454 — intervention group
Group type: EXPERIMENTAL
Intervention: HPS (HumaPen Savvio)
Number of subjects: 203
Study 23438454 — intervention group
Group type: COMPARATOR
Intervention: HPL (HumaPen Luxura)
Number of subjects: 203
Study 22024517 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 3316
Study 22024517 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 3316
Study 22024517 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 3316
Study 22024517 — intervention group
Group type: COMPARATOR
Intervention: Routine laboratory and clinical monitoring (LCM)
Number of subjects: 3316
Study 22024517 — intervention group
Group type: COMPARATOR
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 3316
Study 22024517 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall eGFR changes
Number of subjects: 3316
Study 22024517 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall regimens and monitoring strategies
Number of subjects: 3316
Study 19318873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 18
Study 16306923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet group (MG; n=48)
Number of subjects: 101
Study 16306923 — intervention group
Group type: COMPARATOR
Intervention: Advice-only group (AG; n=53)
Number of subjects: 101
Study 15459142 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive pressure support ventilation (PS‐NI)
Number of subjects: 10
Study 15459142 — intervention group
Group type: COMPARATOR
Intervention: Invasive pressure support ventilation (PS‐I)
Number of subjects: 10
Study 11068083 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of type 2 diabetes
Number of subjects: 189
Study 9069004 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective oropharyngeal decontamination (SOD) with amphotericin B, colistin sulfate, and tobramycin
Number of subjects: 88
Study 9069004 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SOD)
Number of subjects: 88
Study 9069004 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective oropharyngeal decontamination (SOD)
Number of subjects: 88
Study 8087579 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol control of ventilatory management
Number of subjects: 0
Study 8087579 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized therapy via computerized protocols
Number of subjects: 0
Study 3815140 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (1 g intravenous injections, four doses over 12 hours)
Number of subjects: 155
Study 3815140 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole (750 mg intravenous injections, four doses)
Number of subjects: 155
Study 3815140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both antibiotics
Number of subjects: 155
Study 28700102 — intervention group
Group type: EXPERIMENTAL
Intervention: Microletter + short message intervention
Number of subjects: 0
Study 28700102 — intervention group
Group type: COMPARATOR
Intervention: Phone call (control)
Number of subjects: 0
Study 27617500 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 41
Study 27617500 — intervention group
Group type: COMPARATOR
Intervention: Sham taping
Number of subjects: 41
Study 26027135 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementing Qi and activating blood circulation herbs (60 mL per time, 3 times a day for 14 days)
Number of subjects: 67
Study 26027135 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 67
Study 22242558 — intervention group
Group type: EXPERIMENTAL
Intervention: MET/CBT with CM
Number of subjects: 136
Study 22242558 — intervention group
Group type: EXPERIMENTAL
Intervention: MET/CBT without CM
Number of subjects: 136
Study 22242558 — intervention group
Group type: EXPERIMENTAL
Intervention: DC with CM
Number of subjects: 136
Study 22242558 — intervention group
Group type: EXPERIMENTAL
Intervention: DC without CM
Number of subjects: 136
Study 22242558 — intervention group
Group type: EXPERIMENTAL
Intervention: Voucher condition (general attendance)
Number of subjects: 136
Study 20401554 — intervention group
Group type: EXPERIMENTAL
Intervention: Early active mobilization at 5 days (n = 13)
Number of subjects: 24
Study 20401554 — intervention group
Group type: COMPARATOR
Intervention: 4 weeks of immobilization with active motion at 29 days (n = 11)
Number of subjects: 24
Study 18580387 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced strategy (trained nurse promoting provider guideline adherence and patient compliance)
Number of subjects: 291
Study 18580387 — intervention group
Group type: COMPARATOR
Intervention: Basic educational implementation strategy
Number of subjects: 291
Study 18580387 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced strategy
Number of subjects: 291
Study 16161515 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion initiative (intervention group)
Number of subjects: 835
Study 16161515 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 835
Study 12002707 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (Acz) challenged CBF SPET images
Number of subjects: 13
Study 12002707 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 13
Study 10435606 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene (20 mg/d and 80 mg/d)
Number of subjects: 105
Study 10435606 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 7772078 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (50-100 mg on alternate days for 3 weeks after a loading dose of 100 mg/day for 1 week)
Number of subjects: 16
Study 7772078 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (not specified)
Number of subjects: 16
Study 2138875 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin and UV-B
Number of subjects: 82
Study 2138875 — intervention group
Group type: COMPARATOR
Intervention: Placebo and UV-B
Number of subjects: 82
Study 729618 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg
Number of subjects: 9
Study 729618 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiamenidine 1.0 mg
Number of subjects: 9
Study 30995329 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with magnesium (2 g bolus at 30 minutes, 16 mg/24-hour magnesium infusion)
Number of subjects: 50
Study 30995329 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.03-0.3 mg/kg bolus loading dose + 0.03-0.2 mg/kg/hour infusion)
Number of subjects: 50
Study 30995329 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with magnesium
Number of subjects: 50
Study 30995329 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 50
Study 28384091 — intervention group
Group type: EXPERIMENTAL
Intervention: Laid-back breastfeeding position
Number of subjects: 152
Study 28384091 — intervention group
Group type: COMPARATOR
Intervention: Side-lying breastfeeding position
Number of subjects: 152
Study 26036551 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP 10 mm Hg (group P)
Number of subjects: 40
Study 26036551 — intervention group
Group type: COMPARATOR
Intervention: PEEP 0 cm H20 (group K)
Number of subjects: 40
Study 26036551 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (K and P)
Number of subjects: 40
Study 23839667 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intervention (peer modeling explained through photos, video clips, and interactive tasks)
Number of subjects: 141
Study 23839667 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated intervention (similar to standard but included a monkey puppet as a cue reminder)
Number of subjects: 141
Study 23839667 — intervention group
Group type: COMPARATOR
Intervention: Control condition (participants solved a puzzle with a same-sex confederate who was instructed to eat chocolate candy)
Number of subjects: 141
Study 21632728 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery (IMR) program for nine months
Number of subjects: 41
Study 21632728 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control condition)
Number of subjects: 41
Study 19727982 — intervention group
Group type: EXPERIMENTAL
Intervention: BPD-LL with high-calcium diet, 200 IU of vitamin D, and 100 mg elemental calcium daily
Number of subjects: 26
Study 19727982 — intervention group
Group type: COMPARATOR
Intervention: BPD-LL with high-calcium diet, 200 IU of vitamin D, 100 mg elemental calcium daily, and an extra 2 g of calcium
Number of subjects: 26
Study 16703970 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional pain management procedures
Number of subjects: 566
Study 15583768 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care
Number of subjects: 0
Study 11176084 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl at a target plasma concentration of 2.5 ng/ml
Number of subjects: 8
Study 11176084 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia using ropivacaine alone
Number of subjects: 8
Study 11176084 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia using ropivacaine in combination with 2 microg/ml fentanyl
Number of subjects: 8
Study 11176084 — intervention group
Group type: COMPARATOR
Intervention: Control day (no opioid or epidural analgesia)
Number of subjects: 8
Study 9037222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (perioperative injections)
Number of subjects: 18
Study 9037222 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (perioperative injections)
Number of subjects: 18
Study 7880205 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO)
Number of subjects: 0
Study 7880205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3305671 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular replacement of low water content hydrogel lenses
Number of subjects: 48
Study 3305671 — intervention group
Group type: COMPARATOR
Intervention: Non-replacement of low water content hydrogel lenses
Number of subjects: 48
Study 29275147 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (TZDs)
Number of subjects: 2856
Study 27881184 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy (SRT) 16 Gy
Number of subjects: 411
Study 27881184 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 411
Study 24405160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored employment intervention
Number of subjects: 500
Study 22866937 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat group (100 grams of instant oat cereal daily)
Number of subjects: 166
Study 22866937 — intervention group
Group type: COMPARATOR
Intervention: Control group (100 grams of wheat flour-based noodles daily)
Number of subjects: 166
Study 22866937 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat group
Number of subjects: 166
Study 22866937 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study 20339124 — intervention group
Group type: COMPARATOR
Intervention: Emergency medical services use by Mexican Americans
Number of subjects: 1134
Study 20339124 — intervention group
Group type: COMPARATOR
Intervention: Time to hospital arrival within 3 hours by sex
Number of subjects: 1134
Study 20339124 — intervention group
Group type: COMPARATOR
Intervention: Language preference
Number of subjects: 1134
Study 18447136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dpt allergen extract
Number of subjects: 100
Study 18447136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dpt allergen plus mixed respiratory bacterial extracts
Number of subjects: 100
Study 18447136 — intervention group
Group type: EXPERIMENTAL
Intervention: MRB extract only
Number of subjects: 100
Study 18447136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16314625 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic oophorectomy
Number of subjects: 98
Study 16314625 — intervention group
Group type: COMPARATOR
Intervention: Intact ovaries (Control)
Number of subjects: 98
Study 12576820 — intervention group
Group type: EXPERIMENTAL
Intervention: Compact Flex Articulating Linear Cutter (stapling device)
Number of subjects: 70
Study 12576820 — intervention group
Group type: COMPARATOR
Intervention: Traditional suture ligation technique
Number of subjects: 70
Study 10554483 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 24
Study 10554483 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 8831855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (dietary and environmental prevention programme)
Number of subjects: 359
Study 8831855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (breastfed infants)
Number of subjects: 359
Study 8831855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (hydrolysed formula)
Number of subjects: 359
Study 8831855 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group (adapted formula)
Number of subjects: 359
Study 8831855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 359
Study 8831855 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 359
Study 1858439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0
Study 1858439 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 0
Study 1858439 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone
Number of subjects: 0
Study 6401636 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel IUDs
Number of subjects: 6000
Study 6401636 — intervention group
Group type: COMPARATOR
Intervention: Nova-T IUD
Number of subjects: 6000
Study 30659429 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician approach
Number of subjects: 0
Study 30659429 — intervention group
Group type: COMPARATOR
Intervention: Pharmacist approach
Number of subjects: 0
Study 30659429 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician intervention
Number of subjects: 0
Study 30659429 — intervention group
Group type: COMPARATOR
Intervention: Pharmacist intervention
Number of subjects: 0
Study 28262413 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3mg/kg every 2 weeks
Number of subjects: 821
Study 28262413 — intervention group
Group type: COMPARATOR
Intervention: Everolimus 10mg once daily
Number of subjects: 821
Study 28262413 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 821
Study 26051564 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical homeopathic adjunctive therapy
Number of subjects: 410
Study 26051564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no homeopathy)
Number of subjects: 410
Study 23428004 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple bifurcation stenting (provisional T approach)
Number of subjects: 500
Study 23428004 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex bifurcation stenting (crush or culotte approach)
Number of subjects: 500
Study 23428004 — intervention group
Group type: COMPARATOR
Intervention: Both simple and complex strategies
Number of subjects: 500
Study 20652382 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast and cervical educational program (Esperanza y Vida)
Number of subjects: 159
Study 20652382 — intervention group
Group type: COMPARATOR
Intervention: Diabetes program (control)
Number of subjects: 159